Drug Interactions Between Lopinavir/Ritonavir and Oral or Patch Contraceptives in HIV Infected Women
Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the drug interactions between a protease inhibitor
(PI)-based regimen including lopinavir/ritonavir (LPV/r) and two forms of contraceptive
medications in HIV infected women.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)